» Articles » PMID: 1884101

Effects of Propafenone on 45Ca Movements and Contractile Responses in Vascular Smooth Muscle

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1991 Jun 1
PMID 1884101
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

1. In rat isolated aorta the class Ic antiarrhythmic drug, propafenone, dose-dependently inhibited the contractile responses induced by high K (80 mM) and noradrenaline (NA, 10(-5) M), the IC50s being 2.5 +/- 0.7 x 10(-6) M and 8.7 +/- 0.8 x 10(-6) M, respectively. These inhibitory actions were also observed with propafenone added after the induced contractions. 2. Contractile responses induced by addition of Ca to 0 Ca high-K solution were also inhibited by propafenone (IC50 = 2.5 +/- 0.8 x 10(-6) M). Moreover, propafenone inhibited the contractile responses elicited by NA in strips incubated in 0 Ca (IC50 = 1.9 +/- 0.9 x 10(-6) M). 3. Propafenone also inhibited (IC50 = 1.2 +/- 0.4 x 10(-5) M) the development of spontaneous mechanical activity in portal vein segments. 4. Propafenone, 5 x 10(-6) M and 10(-5) M, inhibited 45Ca uptake stimulated by high K or NA without altering 45Ca uptake in resting strips. 5. These results indicated that in rat isolated aortae and portal veins propafenone inhibited Ca entry through voltage-operated channels and NA-induced Ca uptake as well as Ca release from intracellular stores. As a consequence it would reduce the concentration of intracellular free Ca available at the contractile apparatus for vascular smooth muscle contraction.

Citing Articles

Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta.

del Pozo B, Perez-Vizcaino F, Villamor E, Zaragoza F, Tamargo J Br J Pharmacol. 1996; 117(1):105-10.

PMID: 8825350 PMC: 1909366. DOI: 10.1111/j.1476-5381.1996.tb15161.x.


Effects of propafenone on calcium current in guinea-pig ventricular myocytes.

Delgado C, Tamargo J, Henzel D, Lorente P Br J Pharmacol. 1993; 108(3):721-7.

PMID: 8385535 PMC: 1908021. DOI: 10.1111/j.1476-5381.1993.tb12868.x.


Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine.

Perez-Vizcaino F, Fernandez del Pozo B, Zaragoza F, Tamargo J Br J Pharmacol. 1994; 113(4):1281-8.

PMID: 7889284 PMC: 1510496. DOI: 10.1111/j.1476-5381.1994.tb17137.x.


Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Bryson H, Palmer K, Langtry H, Fitton A Drugs. 1993; 45(1):85-130.

PMID: 7680987 DOI: 10.2165/00003495-199345010-00008.


Effects of flecainide on isolated vascular smooth muscles of rat.

Perez-Vizcaino F, Duarte J, Tamargo J Br J Pharmacol. 1991; 104(3):726-30.

PMID: 1797332 PMC: 1908218. DOI: 10.1111/j.1476-5381.1991.tb12495.x.

References
1.
GODFRAIND T, Miller R, Wibo M . Calcium antagonism and calcium entry blockade. Pharmacol Rev. 1986; 38(4):321-416. View

2.
Sigurdsson S, Uvelius B, Johansson B . Relative contribution of superficially bound and extracellular calcium to activation of contraction in isolated rat portal vein. Acta Physiol Scand. 1975; 95(3):263-9. DOI: 10.1111/j.1748-1716.1975.tb10050.x. View

3.
Barrigon S, Tejerina T, Delgado C, Tamargo J . Effects of chlorbutol on 45Ca movements and contractile responses of rat aorta and its relevance to the actions of Syntocinon. J Pharm Pharmacol. 1984; 36(8):521-6. DOI: 10.1111/j.2042-7158.1984.tb04443.x. View

4.
KOHLHARDT M . Block of sodium currents by antiarrhythmic agents: analysis of the electrophysiologic effects of propafenone in heart muscle. Am J Cardiol. 1984; 54(9):13D-19D. DOI: 10.1016/s0002-9149(84)80279-9. View

5.
Harron D, Brogden R . Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs. 1987; 34(6):617-47. DOI: 10.2165/00003495-198734060-00001. View